Status:
COMPLETED
Nationwide Trends in Incidence, Healthcare Utilization, and Mortality in Hospitalized Acute Myocardial Infarction Patients in Taiwan
Lead Sponsor:
Novartis Pharmaceuticals
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
20+ years
Brief Summary
This was a retrospective study using the Taiwan's National Health Insurance Research Database (NHIRD). The study employed two study designs for different purposes as follows: * A cross-sectional anal...
Eligibility Criteria
Inclusion
- Cross-sectional analysis:
- Patients aged 20 years and older.
- Patients who had been admitted for AMI, defined as primary or first secondary diagnosis of AMI between 2014 and 2020.
- The diagnosis of AMI/ STEMI/ NSTEMI was identified by the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes and 10th revision (ICD-10-CM) codes.
- Incident cases of AMI hospitalization were defined as no history of AMI-related hospitalization or outpatient visit within 1 year before admission.
- Longitudinal analysis:
- Patients aged 20 years and older.
- Patients who had been admitted for AMI, defined as primary or first secondary diagnosis of AMI between 2014 and 2017.
- The diagnosis of AMI/ STEMI/ NSTEMI was identified by ICD-9-CM codes and ICD-10-CM codes. (The ICD-9-CM code and ICD-10-CM codes were the same as above)
- Incident cases of AMI hospitalization were defined as no history of AMI-related hospitalization or outpatient visit within 1 year before admission.
- The cohort entry date was defined as the admission date of incident AMI hospitalization, and the index date was defined as the discharge date of incident hospitalization.
Exclusion
- None specified
Key Trial Info
Start Date :
September 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 22 2022
Estimated Enrollment :
124018 Patients enrolled
Trial Details
Trial ID
NCT05974397
Start Date
September 30 2021
End Date
July 22 2022
Last Update
August 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novartis
Taipei, Taiwan